Instil Bio, Inc. (TIL)
Nasdaq: TIL · Biological Products, (No Diagnostic Substances) · Dallas, TX · filing with the SEC since 2019
Who owns Instil Bio, Inc.
As filed with the SECHolders of 5% or more
1
BML Investment Partners, L.P. holds 9.5% of Common Stock, $0.000001 par value per share, as its SCHEDULE 13G/A filed Feb 9, 2026 says.
Directors and officers
5
report now, of 12 people on the record since 2021. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
BML Investment Partners, L.P.
SCHEDULE 13G/A · filed Feb 9, 2026 · Common Stock, $0.000001 par value per share · 6.7% in Feb 13, 2025
Vivo Capital IX, LLC
SCHEDULE 13G/A · filed Aug 12, 2025 · Common stock, par value $ 0.000001 per share · reported falling below 5%
Aaron I. Davis
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, par value $0.000001 · reported falling below 5%
Perceptive Advisors LLC
SCHEDULE 13G/A · filed May 15, 2025 · Common Stock, par value $0.000001 per share · reported falling below 5%
What TIL reports owning in othersstakes of 5% or more, and other ties
5 subsidiaries in 2 countries, from the list filed with the 10-K filed Mar 27, 2026.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.